Terms: = Prostate cancer AND DNM2, CMTDI1, 1785, ENSG00000079805, DYNII, DYN2, CMTDIB
9 results:
1. The Characteristics, Uses, and Biases of Studies Related to Malignancies Using Google Trends: Systematic Review.
Kamiński M; Czarny J; Skrzypczak P; Sienicki K; Roszak M
J Med Internet Res; 2023 Aug; 25():e47582. PubMed ID: 37540544
[TBL] [Abstract] [Full Text] [Related]
2. Cost-effectiveness of Robotic-Assisted Radical prostatectomy for Localized prostate cancer in the UK.
Labban M; Dasgupta P; Song C; Becker R; Li Y; Kreaden US; Trinh QD
JAMA Netw Open; 2022 Apr; 5(4):e225740. PubMed ID: 35377424
[TBL] [Abstract] [Full Text] [Related]
3. Risks and cancer associations of metachronous and synchronous multiple primary cancers: a 25-year retrospective study.
Tanjak P; Suktitipat B; Vorasan N; Juengwiwattanakitti P; Thiengtrong B; Songjang C; Therasakvichya S; Laiteerapong S; Chinswangwatanakul V
BMC Cancer; 2021 Sep; 21(1):1045. PubMed ID: 34556087
[TBL] [Abstract] [Full Text] [Related]
4. Quality of life of elderly patients with solid tumours undergoing adjuvant cancer therapy: a systematic review.
Cheng KK; Lim EY; Kanesvaran R
BMJ Open; 2018 Jan; 8(1):e018101. PubMed ID: 29371271
[TBL] [Abstract] [Full Text] [Related]
5. Use of the prostate Imaging Reporting and Data System (PI-RADS) for prostate cancer Detection with Multiparametric Magnetic Resonance Imaging: A Diagnostic Meta-analysis.
Hamoen EHJ; de Rooij M; Witjes JA; Barentsz JO; Rovers MM
Eur Urol; 2015 Jun; 67(6):1112-1121. PubMed ID: 25466942
[TBL] [Abstract] [Full Text] [Related]
6. The significance of dynamin 2 expression for prostate cancer progression, prognostication, and therapeutic targeting.
Xu B; Teng LH; Silva SD; Bijian K; Al Bashir S; Jie S; Dolph M; Alaoui-Jamali MA; Bismar TA
Cancer Med; 2014 Feb; 3(1):14-24. PubMed ID: 24402972
[TBL] [Abstract] [Full Text] [Related]
7. Body composition changes during androgen deprivation therapy for prostate cancer: a 2-year prospective study.
van Londen GJ; Levy ME; Perera S; Nelson JB; Greenspan SL
Crit Rev Oncol Hematol; 2008 Nov; 68(2):172-7. PubMed ID: 18706829
[TBL] [Abstract] [Full Text] [Related]
8. Predictors of short postoperative prostate-specific antigen doubling time for patients diagnosed during PSA era.
Lin DD; Schultz D; Renshaw AA; Rubin MA; Richie JP; D'Amico AV
Urology; 2005 Mar; 65(3):528-32. PubMed ID: 15780370
[TBL] [Abstract] [Full Text] [Related]
9. Regulation of microtubule, apoptosis, and cell cycle-related genes by taxotere in prostate cancer cells analyzed by microarray.
Li Y; Li X; Hussain M; Sarkar FH
Neoplasia; 2004; 6(2):158-67. PubMed ID: 15140405
[TBL] [Abstract] [Full Text] [Related]
